Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Aquestive Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 51 | 46 | −5 |
| Shares | 15.5M | 16.6M | +1.09M (+7.0%) |
| Value | $40.6M | $10.7M | −$29.9M (−73.6%) |
New holders (5)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cowen and Company, LLC | 124,590 | $80.0K | 0.01% |
| Mackenzie Financial Corp | 61,699 | $39.0K | 0.00% |
| Beacon Pointe Advisors, LLC | 60,000 | $38.0K | 0.00% |
| Engineers Gate Manager LP | 18,261 | $12.0K | 0.00% |
| D.B. Root & Company, LLC | 12,500 | $7.00K | 0.00% |
Sold out (10)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Graypoint LLC | 413,817 | $1.08M |
| HighTower Advisors, LLC | 130,305 | $340.0K |
| PDT Partners, LLC | 101,456 | $265.0K |
| Jacobs Levy Equity Management, Inc | 63,577 | $166.0K |
| Susquehanna International Group, LLP | 48,511 | $126.0K |
| Gsa Capital Partners LLP | 34,769 | $91.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 31,396 | $82.0K |
| Barclays PLC | 24,829 | $65.0K |
| ExodusPoint Capital Management, LP | 11,140 | $29.0K |
| Royal Bank of Canada | 1,600 | $4.00K |